SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Life Sciences to consolidate Pharmaceutical Segment under two separate verticals

29 May 2013 Evaluate

Jubilant Life Sciences has received an approval to consolidate the company’s Pharmaceutical Segment under two separate verticals, one comprising of Active Pharmaceuticals Ingredients, Solid Dosage Form, Radio Pharmaceuticals, Allergic Extracts, Sterile Injectable and Ointment, Cream and Liquid businesses (Pharma Business) and other Drug Discovery Businesses, subject to all necessary approvals/ consents/ permissions and sanctions. The board of directors at its meeting held on May 28, 2013 has approved for the same.

The board has also approved to constitute a committee to decide the modalities of consolidating the Pharma Business and the Drug Discovery Business under two separate subsidiaries of the company and explore, identify and implement the options and opportunities of raising money by listing the Pharma business for its growth and reduction of overall consolidated debt of the company.

Jubilant Life Sciences is an integrated Pharmaceuticals and Life Sciences Company. It is the largest Custom Research and Manufacturing Services (CRAMS) player and a leading Drug Discovery and Development Solution provider out of India.

Jubilant Pharmova Share Price

911.60 6.55 (0.72%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×